Additionally, the TMB of EGFR fusion patients was further analyzed, which indicated that the TMB of EGFR fusion was higher than that of non-EGFR fusion but with no statistical significance, no matter in pan cancer or in the lung, gastric cancer, and glioma. The gene discussed is EGFR; the disease is glioma.